More than 800 million individuals have diabetes globally, doubling in the last three decades according to research recently ...

The fight against type 2 diabetes just reached a groundbreaking milestone. Last week, the U.S. Food and Drug Administration ...

Lawsuits filed in New Jersey are part of hundreds of complaints against UnitedHealthcare, PBMs, and pharmaceutical giants ...

The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...

Icovamenib met the primary endpoint, displaying a meaningful statistically significant placebo-corrected mean reduction in HbA1c in the ...

Researchers found a 3% lower risk of Type 2 diabetes for each additional weekly ... than 190,000 health care professionals in the United States for over 30 years. Instead, the study showed ...

Health knowledge about sugar-sweetened beverages (SSBs) does not significantly reduce high SSB consumption, which is driven ...

A more precise risk calculation also benefits diabetes screening programs that have become more common in the United States and around the world. Jacobsen, the lead author in the “personal views ...

Cal Poly has received a $10.6 million grant from the nonprofit Patient-Centered Outcomes Research Institute (PCORI) ...

As Novo Nordisk and Eli Lilly expand sales of their popular diabetes and weight-loss drugs, cheaper copies of their patented ...